Bridge Therapy Between Induction, ASCT May Slow Neuroblastoma
Three-year event-free survival significantly improved for patients with end-induction stable metastatic disease receiving bridge therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.